RFL
Rafael Holdings, Inc.Company Information
- Company Name
- Rafael Holdings, Inc.
- CIK
- CIK0001713863
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- RFL: NYSE
- Fiscal Year End
- July 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- RFL
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-06-05
- Last sale
- 2022-08-09
- Shares purchased (TTM)
- 13,080,457
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 3,786,451
- Shares outstanding
- 51,229,576
- Ownership
- 7.39%
Earnings Market Reaction
- Filing date
- 2026-06-11
- Price on filing date
- —
- 1-month reaction
- 48.58%
- 3-month reaction
- 20.75%
Balance Sheet
Values in millions ($)| Line item | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cyclo | - | - | - | - | - | 3 | 8 | 12 | - | - | - | 5 | ||||||
| Hedge Funds | - | - | - | - | - | - | - | 3 | -0 | 0 | 2 | 5 | ||||||
| I N V E S T M E N T I N D A Y T H R E E L A B S I N C | - | - | - | - | - | - | - | - | - | - | 3 | 3 | ||||||
| Related Party | -0 | -0 | 1 | 1 | - | - | - | 1 | -1 | 0 | 2 | 2 | ||||||
Assets Current | ||||||||||||||||||
| Investment In Cyclo Therapeutics Inc | - | - | - | - | - | - | - | - | - | - | 10 | 5 | ||||||
| Day Three Labs Inc | - | - | - | - | - | - | - | - | - | - | - | 3 | ||||||
| Other Pharmaceuticals | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Cyclo Therapeutics Inc | - | - | - | - | - | - | - | - | -4 | 20 | - | - | ||||||
| Cash And Cash Equivalents At Carrying Value | 30 | 38 | 46 | 53 | 38 | 48 | 8 | 3 | 7 | 7 | 13 | 21 | ||||||
| Assets Held For Sale Not Part Of Disposal Group Current | - | - | - | - | - | - | - | - | - | - | 59 | - | ||||||
| Available For Sale Securities Debt Securities Current | - | - | - | - | - | - | 46 | 63 | 65 | 65 | - | 58 | ||||||
| Interest Receivable Current | - | - | - | - | - | - | 0 | 1 | 1 | 1 | 0 | 0 | ||||||
| Receivables Net Current | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Accounts And Other Receivables Net Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Other Receivables | - | - | - | - | - | - | - | - | - | 0 | - | - | ||||||
| Other Receivables Net Current | - | - | - | 1 | - | - | - | - | - | - | - | - | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 0 | 0 | 0 | 3 | 1 | ||||||
| Equity Securities Fv Ni | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Assets Current | 35 | 42 | 48 | 57 | 42 | 66 | 70 | 73 | 74 | 75 | 77 | 83 | ||||||
| Property Plant And Equipment Net | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Deferred Tax Assets In Process Research And Development | - | - | - | - | - | - | - | - | - | - | 2 | - | ||||||
| Goodwill | 20 | 20 | 20 | 20 | 28 | - | 3 | 3 | 4 | 3 | - | - | ||||||
| Intangible Assets Net Excluding Goodwill | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | - | - | ||||||
| Long Term Investments | 1 | 1 | 1 | - | - | - | - | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 92 | 99 | 105 | 114 | 108 | 83 | 88 | 97 | 102 | 106 | 96 | 99 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 7 | 8 | 7 | 7 | 8 | 3 | 3 | 3 | 3 | 1 | - | 0 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accrued Liabilities Current | 3 | 3 | 4 | 3 | 2 | 1 | 1 | 2 | 2 | 1 | 0 | 1 | ||||||
| Other Notes Payable Current | - | - | 1 | - | - | 2 | 2 | 2 | 2 | - | - | - | ||||||
| Convertible Notes Payable Current | 1 | 1 | - | 1 | 1 | 1 | 1 | 1 | 1 | - | - | - | ||||||
| Other Liabilities Current | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Notes Payable Current | - | - | - | - | - | - | - | - | - | 2 | 0 | - | ||||||
| Liabilities Current | 11 | 12 | 12 | 12 | 11 | 7 | 7 | 8 | 8 | 3 | 1 | 2 | ||||||
| Accrued Liabilities And Other Liabilities | - | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | - | - | - | ||||||
| Convertible Long Term Notes Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Deferred Income Tax Liabilities Net | 0 | 0 | 0 | 0 | 9 | - | - | 0 | 1 | 1 | - | - | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 11 | 16 | 16 | 16 | 24 | 10 | 10 | 11 | 11 | 4 | 1 | 2 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | - | - | - | - | 9 | - | - | - | - | - | - | - | ||||||
| Additional Paid In Capital Common Stock | 323 | 323 | 323 | 322 | 297 | 281 | 280 | 280 | 280 | 266 | 265 | 264 | ||||||
| Retained Earnings Accumulated Deficit | -253 | -248 | -242 | -232 | -220 | -215 | -211 | -202 | -197 | -165 | -171 | -167 | ||||||
| Treasury Stock Common Value | - | - | - | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | - | ||||||
| Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 | ||||||
| Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | ||||||
| Stockholders Equity | 75 | 79 | 89 | 94 | 81 | 73 | 77 | 86 | 86 | 102 | 95 | 100 | ||||||
| Minority Interest | 5 | 4 | 4 | 4 | 4 | 3 | 4 | 4 | 4 | -3 | -4 | -4 | ||||||
| Liabilities And Stockholders Equity | 92 | 99 | 105 | 114 | 108 | 83 | 88 | 97 | 102 | 106 | 96 | 99 | ||||||
| Common Class A | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | - | - | - | - | - | 0.63 | - | - | - | - | - | - | ||||||
| Common Class B | -0 | 0 | 51 | 0 | 7 | 0 | 24 | 0 | -0 | 0 | 24 | 0 | ||||||
| Class B Treasury Stock | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | ||||||
| Common Stock Shares Issued | - | - | - | - | 13 | 4 | - | - | - | - | - | - | ||||||
| Treasury Stock Common Shares | - | - | - | 0 | 0 | - | - | 0 | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialRafael Holdings, Inc. (RFL) — SEC Financial Statements & Analysis
Rafael Holdings, Inc. (RFL) is a pharmaceutical preparations company, incorporated in DE. Rafael Holdings, Inc. trades on NYSE as: RFL. Rafael Holdings, Inc. (RFL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-04-30, filed with the SEC on 2026-06-11. Based on that filing, Rafael Holdings, Inc. carries a market cap of $65.06M, a P/E ratio of -1.95x, a P/B ratio of 0.86x, a P/S ratio of 66.39x, an enterprise value of $35.17M, and an EV/EBITDA multiple of -0.97x. On profitability, it posts a gross margin of 114.18%, an operating margin of -3717.24%, a net margin of -3396.02%, a Return on Equity (ROE) of -42.68%, a Return on Assets (ROA) of -33.27%, and a Return on Invested Capital (ROIC) of -81.99%. Per share, it reports EPS of $-0.65, diluted EPS of $-0.65, free cash flow per share of $-0.62, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 33.88% year-over-year, net income growth of 50.14% year-over-year, and EPS growth of -26.03% year-over-year. On the balance sheet, it maintains a current ratio of 3.16x, a quick ratio of 3.06x, working capital of $23.84M, a debt-to-equity ratio of 0.15x, a debt ratio of 0.12, an interest coverage ratio of -73.59x, free cash flow of $-32.00M (TTM), and net debt of $-29.89M. Figures sourced from SEC EDGAR.
- Market Cap
- $65.06M
- P/E TTM
- -1.95x
- EPS TTM
- $-0.65
- P/B TTM
- 0.86x
- ROE TTM
- -42.68%
- ROA TTM
- -33.27%
- Debt To Equity
- 0.15x
- Free Cash Flow TTM
- $-32.00M
- Net Revenue TTM Growth 1Y
- 33.88%
Data as of 2026-04-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Rafael Holdings, Inc. in?
Rafael Holdings, Inc. (RFL) operates in the Pharmaceutical Preparations industry.
What exchange does RFL trade on?
Rafael Holdings, Inc. (RFL) trades on the NYSE.
Where is Rafael Holdings, Inc. incorporated?
Rafael Holdings, Inc. is incorporated in DE.
When was Rafael Holdings, Inc. (RFL)'s most recent SEC filing?
Rafael Holdings, Inc. (RFL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-04-30, filed with the SEC on 2026-06-11.
What is RFL's market cap?
Rafael Holdings, Inc. (RFL) has a market capitalization of $65.06M as of 2026-04-30.
What is RFL's EPS (earnings per share)?
Rafael Holdings, Inc. (RFL)'s trailing twelve month EPS is $-0.65 as of 2026-04-30.
What is RFL's ROE (return on equity)?
Rafael Holdings, Inc. (RFL)'s trailing twelve month Return on Equity (ROE) is -42.68% as of 2026-04-30.
What is RFL's ROA (return on assets)?
Rafael Holdings, Inc. (RFL)'s trailing twelve month Return on Assets (ROA) is -33.27% as of 2026-04-30.
What is RFL's ROIC (return on invested capital)?
Rafael Holdings, Inc. (RFL)'s trailing twelve month Return on Invested Capital (ROIC) is -81.99% as of 2026-04-30.
What is RFL's EV/EBITDA?
Rafael Holdings, Inc. (RFL)'s trailing twelve month EV/EBITDA is -0.97x as of 2026-04-30.